Home / Expertise / Life Sciences & Healthcare
Lab

Life Sciences & Healthcare

United Arab Emirates

Dubai’s vision to become a hub for healthcare tourism, the rapid expansion of local and expat populations across the Middle East, as well as the region’s unique demographics, give rise to opportunities and challenges for investors in the lifesciences and healthcare sectors.

We work with and have established long-term relationships with the top 100 lifesciences companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.  We also support clinics, hospitals, and other service providers active in the healthcare sector, and private investors in such businesses, across the Middle East. Our experts advise leading global business groups in the sector on transactions, commercial agreements, compliance, investigations and litigation, very often across multiple jurisdictions in the region and beyond. We can help you to navigate the regulatory landscape and to ensure compliance with both local laws and global policies.

With over 150 international specialist lawyers across CMS, we understand the scientific and commercial as well as the legal imperatives affecting your lifesciences and healthcare businesses. Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the lifesciences sector. We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice.

Read more Read less
High­lights of our ex­per­i­ence in Lifes­ci­ences in UAE
An In­ter­na­tion­al Health­care Ser­vices pro­vider on its con­tract for the pro­vi­sion of health­care ser­vices to the UAE Mil­it­aryZentiva NV on its ac­quis­i­tion of 75% of Ecza­cibasi Gen­er­ic Phar­ma­ceut­ic­als in Tur­key for €460 mil­lion.In­ter­na­tion­al med­ic­al device man­u­fac­turer on reg­u­lat­ory is­sues in UAE and the es­tab­lish­ment of health­care ser­vices in UAE.Eth­emba Cap­it­al and NBGI Private Equity on the ac­quis­i­tion of a con­trolling stake in the Birgi Me­far Group in Tur­key for £20 mil­lion.An in­ter­na­tion­al health­care pro­vider on its pro­pos­als for the de­vel­op­ment of a series of primary health­care fa­cil­it­ies in UAE.A war­ranty and in­dem­nity in­surer on its cov­er­age on the ac­quis­i­tion of NMC Health­care and a health­care fa­cil­ity in UAE.Please down­load the print ver­sion be­low.

Feed

Show only
Dec 2018
CMS Life Sci­ences & Health­care Sec­tor Group: An over­view of our Asia-Pa­cific,...
20 April 2020
CMS Ex­pert Guide to ad­vert­ising of medi­cines and med­ic­al devices
Are you look­ing for in­form­a­tion on phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising? Learn more about it in this CMS Ex­pert Guide.
08 July 2020
“WIPO PROOF”: WIPO’s new on­line ser­vice which helps in­nov­at­ors and cre­at­ors...
The World In­tel­lec­tu­al Prop­erty Or­gan­isa­tion (WIPO) re­cently launched its new on­line busi­ness ser­vice, “WIPO PROOF”. The plat­form aims to help in­nov­at­ors and cre­at­ors safe­guard their in­tel­lec­tu­al...
1 May 2017
CMS, Nabarro and Olswang com­plete ground­break­ing mer­ger
CMS UK, Nabarro and Olswang today an­nounce the com­ple­tion of their trans­form­a­tion­al mer­ger, cre­at­ing the 6th largest law firm glob­ally by head­count. Trad­ing as CMS, and with 70 of­fices across 39 coun­tries, the new firm blends scale with an ex­cep­tion­al dep
20 April 2020
CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
Are you look­ing for in­form­a­tion on can­nabis law and le­gis­la­tion? This CMS Ex­pert Guide provides you with everything you need to know.
22 May 2020
For­eign in­vest­ments in Ger­man life sci­ence com­pan­ies be­come sub­ject to...
In re­sponse to the COV­ID-19 pan­dem­ic, Ger­many has widened the scope of its in­vest­ment con­trol to in­clude nu­mer­ous life sci­ence com­pan­ies. The amend­ments to the For­eign Trade and Pay­ments Or­din­ance ("AWV")...
07/03/2016
CMS builds Is­lam­ic Fin­ance Prac­tice with new part­ner ap­point­ment
04 May 2020
EPO Board of ap­peal re­mits to ex­amin­ing di­vi­sion when pri­or art search...
In Mod­el de­term­in­a­tion sys­tem/Ac­cen­ture Glob­al Ser­vices Lim­ited (Case T-1159/15), the board of ap­peal finds that need to per­form a pri­or art search con­sti­tutes a spe­cial reas­on to re­mit the ap­peal ap­plic­a­tion...
30 April 2020
USPTO finds an in­ven­tion cre­ated by an AI ma­chine is not pat­entable
The US Pat­ent and Trade Mark Of­fice has found that DABUS is not a per­son and so can­not be con­sidered an in­vent­or of a pat­ent. DABUS is an ar­ti­fi­cial in­tel­li­gence (AI) ma­chine. The USPTO ac­cep­ted the in­dic­a­tion...
07 April 2020
Coronavir­us and the food in­dustry: The UAE’s law to reg­u­late the stra­tegic...
Cor­rect as of 9am, 6th April. This art­icle is not be­ing main­tained. While the food and ag­ri­cul­tur­al sec­tor should in prin­ciple be less af­fected by the Cov­id-19 pan­dem­ic than oth­ers, la­bour short­ages,...
17 March 2020
While doc­tors fight COV­ID-19 au­thor­it­ies battle fraud, price hikes and...
In every coun­try hit by COV­ID-19, the dis­ease linked to the Coronavir­us, com­pet­i­tion and con­sumer pro­tec­tion au­thor­it­ies have been con­fron­ted with the vir­us's im­plic­a­tions. Gov­ern­ments, au­thor­it­ies and...
31 January 2020
UK In­tel­lec­tu­al Prop­erty Of­fice finds that pat­ent law does not cater for...
The UK In­tel­lec­tu­al Prop­erty Of­fice has found that DABUS is not a per­son and so can­not be con­sidered an in­vent­or of a pat­ent. DABUS is an ar­ti­fi­cial in­tel­li­gence (AI) ma­chine. The UKIPO ac­cep­ted the in­dic­a­tion...